GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Petlife Pharmaceuticals PTLF · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

About Petlife Pharmaceuticals

Its shares trade under the ticker PTLF.

Petlife Pharmaceuticals, Inc. engages in the research, development, sales, and support of drugs and nutraceuticals for pet cancer and autoimmune related diseases. The company is headquartered in Los Angeles, California. The firm specializes in the research, development, sales and support of drugs and nutraceuticals for pet cancer and autoimmune related diseases, such as arthritis. The firm has developed and is launching veterinary cancer medications and nutraceuticals, based on the Escozine formula. The firm has rights to formulate, package and market a product line, Vitalzul. Vitalzul is a polarized, bioactive peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps), which contains amino acids, proteins and minerals. Vitalzul inhibits blood vessels formation in solid tumors. Escozine has been used in combination with chemotherapy, radiation, hormone therapy and other conventional treatments. As of August 31, 2016, Escozine (for humans) was sold as either a nutraceutical or prescription drug in 40 countries, including the United States.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
N/A
Industry
N/A
Employees
2

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Petlife Pharmaceuticals Inc has several strengths that contribute to its success:

Weaknesses

  • Despite its strengths, Petlife Pharmaceuticals Inc also faces certain weaknesses:

Opportunities

  • There are several opportunities that Petlife Pharmaceuticals Inc can capitalize on:

Threats

  • Petlife Pharmaceuticals Inc should be aware of the following threats to its business:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.